Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs).

We regretfully announce the resignation of Dr. Fred R. Hirsch from the IASLC CEO position effective Oct. 31, 2018, upon completion of his current five-year contract.

Professor Françoise Mornex, M.D., Ph.D., will be recognized by the International Association for the Study of Lung Cancer (IASLC) with a Distinguished Award at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada.

Free ME From Lung Cancer (FMFLC) and the International Association for the Study of Lung Cancer (IASLC) today announced the first ever winner of the FMFLC-IASLC Foundation Joint Fellowship Award for the Early Detection of Lung Cancer.

Oncologist and professor Ignacio I. Wistuba, M.D., of The University of Texas MD Anderson Cancer Center, will be recognized by the International Association for the Study of Lung Cancer (IASLC) with a Distinguished Award at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada.

Renowned oncologist, physician and professor, Fadlo R. Khuri, M.D., FACP, will be recognized by the International Association for the Study of Lung Cancer (IASLC) with a Distinguished Award at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada.